PT-141 (Bremelanotide) — Hermetica Encyclopedia
Amino Acid & Peptide · Peptide

PT-141 (Bremelanotide)

Strong Evidenceamino_acid2 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

PT-141 (Bremelanotide) is a synthetic peptide that activates melanocortin-4 receptors in the hypothalamus to enhance sexual arousal and desire. This FDA-approved medication works through central nervous system pathways rather than vascular mechanisms.

2
PubMed Studies
1
Validated Benefits
Synergy Pairings
At a Glance
CategoryAmino Acid & Peptide
GroupPeptide
Evidence LevelStrong
Primary KeywordPT-141 benefits
Synergy Pairings4
PT-141 (Bremelanotide) — botanical
PT-141 (Bremelanotide) — botanical close-up

Health Benefits

Enhances sexual arousal and desire by activating melanocortin receptors in the brain, leading to increased libido. - May improve erectile function in men by promoting nitric oxide release and vascular dilation. - Increases sexual satisfaction and frequency of intimacy, with studies showing up to 50% improvement in responsiveness. - Supports healthy sexual function in women, especially those with hypoactive sexual desire disorder (HSDD). - Reduces sexual performance anxiety by balancing stress-related neurotransmitters. - Stimulates dopamine pathways, elevating mood and pleasure associated with intimacy. - Offers rapid onset of action, with effects often felt within 30-60 minutes. - Can help restore intimacy and confidence in relationships by addressing both psychological and physiological barriers.

Origin & History

PT-141 (Bremelanotide) — origin
Natural habitat

PT-141, also known as Bremelanotide, is a synthetic peptide derived from the melanocortin receptor agonist family. It is produced through chemical synthesis and is primarily used for its potential effects on sexual arousal.

Developed in the early 2000s, PT-141 was initially researched for tanning effects before its sexual arousal properties were discovered.Traditional Medicine

Scientific Research

PT-141 has been studied in clinical trials for its effects on sexual arousal and erectile dysfunction, showing promising results. Further studies are ongoing.

Preparation & Dosage

PT-141 (Bremelanotide) — preparation
Traditional preparation

Typical dosage is 1.75 mg administered via subcutaneous injection as needed. Consult a healthcare provider before use.

Nutritional Profile

- Composed of a sequence of amino acids. - Administered via subcutaneous injection. - Acts on melanocortin receptors in the brain.

How It Works

Mechanism of Action

PT-141 selectively binds to melanocortin-4 (MC4R) and melanocortin-1 (MC1R) receptors in the hypothalamic paraventricular nucleus. This binding activates cyclic adenosine monophosphate (cAMP) signaling pathways that modulate dopaminergic and noradrenergic neurotransmission. The resulting neural cascade enhances sexual motivation and arousal through central nervous system stimulation rather than peripheral vascular effects.

Clinical Evidence

Clinical trials included over 1,200 premenopausal women with hypoactive sexual desire disorder (HSDD). Phase 3 studies showed significant improvements in sexual desire scores on the Female Sexual Function Index, with 25% more participants achieving meaningful increases compared to placebo. Men's studies demonstrated improved erectile function scores by 2-3 points on the International Index of Erectile Function. Evidence quality is strong for women with HSDD, with FDA approval granted in 2019.

Safety & Interactions

Common side effects include nausea (up to 40% of users), flushing, and headache, typically occurring within 2 hours of injection. PT-141 may interact with blood pressure medications due to potential hypotensive effects. Contraindicated in patients with uncontrolled hypertension or cardiovascular disease. Safety during pregnancy and breastfeeding has not been established, and use is not recommended.

Synergy Stack

Hermetica Formulation Heuristic

Frequently Asked Questions

How long does PT-141 take to work?
PT-141 typically begins working within 45 minutes to 2 hours after subcutaneous injection. Peak effects occur around 2-3 hours post-injection and can last up to 24 hours.
What is the typical PT-141 dosage?
The standard PT-141 dose is 1.75 mg administered subcutaneously at least 45 minutes before anticipated sexual activity. Maximum frequency is once every 24 hours, with no more than 8 doses per month recommended.
Can PT-141 be taken with Viagra or Cialis?
PT-141 can potentially be used alongside PDE5 inhibitors like Viagra since it works through different mechanisms (central vs. peripheral). However, combination use should only occur under medical supervision due to potential blood pressure effects.
Does PT-141 work for both men and women?
PT-141 is FDA-approved specifically for premenopausal women with hypoactive sexual desire disorder. While studies show promise in men for erectile dysfunction, it lacks FDA approval for male sexual dysfunction treatment.
Is PT-141 the same as Melanotan II?
PT-141 is a modified version of Melanotan II with reduced melanocortin-1 receptor activity, minimizing skin darkening effects. PT-141 specifically targets sexual function while Melanotan II has broader melanocortin receptor activity affecting skin pigmentation.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.